p.97 抽出テキスト

Kusumoto et al 2018 Bradycardia Clinical Practice Guidelines

August 20, 2019 Circulation. 2019;140:e382–e482. DOI: 10.1161/CIR.0000000000000628 e478

CLINICAL STATEMENTS AND GUIDELINES S12-6.	 Hoijer CJ, Brandt J, Willenheimer R, et al. Improved cardiac function

and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation. Eur Heart J. 2002;23:490–7. S12-7.	 Lau CP, Tai YT, Lee PW, et al. Quality-of-life in DDDR pacing: atrioventricular synchrony or rate adaptation? Pacing Clin Electrophysiol. 1994;17:1838–43. S12-8.	 Lukl J, Doupal V, Heinc P. Quality-of-life during DDD and dual sensor VVIR pacing. Pacing Clin Electrophysiol. 1994;17:1844–48. S12-9.	 Ouali S, Neffeti E, Ghoul K, et al. DDD versus VVIR pacing in patients, ages 70 and over, with complete heart block. Pacing Clin Electrophysiol. 2010;33:583–9. S12-10.	 Deharo JC, Badier M, Thirion X, et al. A randomized, single-blind

crossover comparison of the effects of chronic DDD and dual sensor VVIR pacing mode on quality-of-life and cardiopulmonary performance in complete heart block. Pacing Clin Electrophysiol. 1996;19:1320–6.

13 DISCONTINUATION OF

PACEMAKER THERAPY

S13-1.	 Iskos D, Lurie KG, Sakaguchi S, et al. Termination of implantable pacemaker therapy: experience in five patients. Ann Intern Med. 1997;126:787–90. S13-2.	 Martinelli M, Costa R, Nishioka S, et al. Criteria for pacemaker explant in patients without a precise indication for pacemaker implantation. Pacing Clin Electrophysiol. 2002;25:272–7. S13-3.	 Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;127:e283–352. S13-4.	 Kowey PR. The unnecessary pacemaker controversy revisited. Pacing Clin Electrophysiol. 2002;25:269–71. S13-5.	 Stegman SS, Burroughs JM, Henthorn RW. Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin Electrophysiol. 1996;19:899–904. S13-6.	 Greenspan AM, Kay HR, Berger BC, et al. Incidence of unwarranted implantation of permanent cardiac pacemakers in a large medical population. N Engl J Med. 1988;318:158–63. S13-7.	 Al-Hijji MA, Killu AM, Yousefian O, et al. Outcomes of lead

extraction without subsequent device reimplantation. Europace. 2017;19:1527–34. 14 END-OF-LIFE CONSIDERATIONS

S14-1.	 Mueller PS, Jenkins SM, Bramstedt KA, et al. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol. 2008;31:560–8. S14-2.	 Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7:1008–26. S14-3.	 Mueller PS, Hook CC, Hayes DL. Ethical analysis of withdrawal of

pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc. 2003;78:959–63.

15 KNOWLEDGE GAPS AND FUTURE

RESEARCH

S15-1.	 Lustgarten DL, Calame S, Crespo EM, et al. Electrical resynchronization induced by direct His-bundle pacing. Heart Rhythm. 2010;7:15–21. S15-2.	 Deshmukh P, Casavant DA, Romanyshyn M, et al. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation. 2000;101:869–77. S15-3.	 Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE- 3): a randomized trial. Circulation. 2012;125:2566–71. S15-4.	 Varosy PD, Chen LY, Miller AL, et al. Pacing as a treatment for reflexmediated (vasovagal, situational, or carotid sinus hypersensitivity) syncope: a systematic review for the 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e123–35. S15-5.	 Curtis AB, Worley SJ, Chung ES, et al. Improvement in clinical outcomes with biventricular versus right ventricular pacing: The BLOCK HF Study. J Am Coll Cardiol. 2016;67:2148–57. S15-6.	 Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368:1585–93. S15-7.	 Reynolds D, Duray GZ, Omar R, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374:533–41. S15-8.	 Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous implanta-

tion of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125–35.

Downloaded from http://ahajournals.org by on October 7, 2026